home > News and Publications > Publications
 

  • Your Help Needed! Contact Your State Representative to Urge Support of Prior Authorization Reform

    It’s time to fix prior authorization in Illinois

    Legislation designed to address bureaucratic delays caused by prior authorization is advancing in Springfield.

    Known as the Prior Authorization Reform Act, this initiative would establish deadlines for prior authorization decisions – 24 hours for urgent care services and 72 hours for nonurgent care – so patients would no longer have to worry about insurers’ decision-making delays causing further damage to their health. 

    The Act would also ensure that prior authorization requirements are based on medical evidence and that decisions are administered by qualified professionals.

    Last month, the ISMS-backed legislation (House Bill 711 and Senate Bill 177) was introduced in Springfield. Earlier this week, House Bill 711 was assigned to the Human Services Committee and is expected to be heard on the House floor next Tuesday. 

    ISMS appreciates the bipartisan support from more than 50 house co-sponsors who are dedicated to ensuring timely patient care to protect the residents of Illinois!

    Yet, your help is still needed. Please contact your state representative today and urge support of House Bill 711 – The Prior Authorization Reform Act.

    Our message to Illinois patients is simple: Your care can’t wait!

    Learn more at www.YourCareCantWait.org.

    If you have questions, please contact ISMS Senior Vice President of Legislative Affairs Erin O'Brien by email



  • FDA Approves University of Illinois’ Saliva COVID-19 Test for Emergency Use Authorization

    The COVID-19 saliva test developed by University of Illinois researchers, known as covidShield, was listed as one of the U.S. Food and Drug Administration (FDA)’s approved molecular diagnostic tests as of Feb. 24, 2021

    Although this rapid saliva-based COVID-19 test recently obtained FDA emergency use authorization, students, campus staff and faculty at all three campuses – Urbana-Champaign, Springfield and Chicago – were already using covidShield because the tests were developed and analyzed in state-certified campus labs.

    Governor Pritzker is now allocating $20 million in CARES Act funding to expand the saliva test to the state’s nine other public universities and 48 community colleges. 

    Some of the benefits of covidShield include: 

    • Low cost: $20 to $30 a test compared to $100 or more for nasal swab tests

    • Quick turnaround time of less than 24 hours

    • The tests do not need medically trained staff to collect samples

    • The test is highly accurate

    If you have questions, please contact the ISMS Health Policy Research and Advocacy team  by email



  • ISMS Member Making a Difference in the Fight Against COVID-19
    ISMS caught up with ISMS member Tripti C. Kataria, MD, to speak with her about her volunteer work vaccinating the general public. Dr. Kataria is an anesthesiologist practicing in Chicago and currently serves as chair of the ISMS Governmental Affairs

  • Register Now for These Live Webinars – at No Cost!

    What Physicians and Their Patients Need to Know About COVID-19 Vaccine Development, Safety and Administration

    March 15 | Noon to 1 p.m.

    As the global SARS-CoV-2 pandemic nears its one-year anniversary, an unprecedented effort to develop, distribute and administer vaccines to combat the virus is underway. The FDA’s approval for emergency use of multiple COVID-19 vaccines is a great success, but approval is just the beginning of the mass vaccination effort. This webinar will feature experts discussing approved vaccines, vaccine safety and the physician’s role in the COVID-19 vaccination effort.

    • ISMS members, ISMIE policyholders and their staffs can participate at no cost.
    • CME offered | Register here

    Medication Safety Considerations During the COVID-19 Pandemic

    March 16 | Noon to 1 p.m.

    In the midst of the pandemic, information related to medications used for COVID-19 treatment is rapidly changing. This could pose significant risks, including adverse drug interactions and polypharmacy, for physicians and patients when adding COVID-19 treatments to a patient’s medication regimen.

    Minimizing this risk is of utmost importance in providing safe patient care.

    Join ISMIE Mutual’s* webinar to address this risk, covering risk management strategies for COVID-19 treatments and supportive/alternative therapies, along with the latest guidance and common adverse effects.

    • ISMS members, ISMIE policyholders and their staffs can participate at no cost.
    • CME offered | Register here.

      *As ISMS’ endorsed carrier, ISMIE has allowed special access to this activity to ISMS members.



  • Take Control of Your Career!

    If you want a leg up in your search for new career opportunities, or if you’re trying to identify promising candidates, then tap ISMS’ Career Center

    There are no fees for job seekers. This online resource is connected to a national job bank that features thousands of listings for physicians, other clinicians and practice management professionals.

    ISMS member offices receive discounted rates for job postings:

    • $115 to post a job opening for 30 days ($400 for non-members)

    • $175 for 60 days ($500 for non-members)

    This ISMS member benefit is just one of many provided through our Benefit Partners.

    Check out the Career Center today!  




View Full Site View Mobile Site